Discussion about this post

User's avatar
Trevor Klee's avatar

Looks like Veozah caused liver injury in someone (https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due). Makes me wonder if that's a risk of neurokinin-3 receptor antagonists. I'm guessing Bayer will be worried about that as well.

Expand full comment
3 more comments...

No posts